KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio (2018 - 2025)

TherapeuticsMD filings provide 12 years of Interest Coverage Ratio readings, the most recent being 287.33 for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 23.99% to 287.33 in Q3 2025 year-over-year; TTM through Mar 2026 was 766.4, a 30.87% decrease, with the full-year FY2021 number at 3.53, up 40.95% from a year prior.
  • Interest Coverage Ratio hit 287.33 in Q3 2025 for TherapeuticsMD, up from 347.5 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.24 in Q1 2022 to a low of 640.5 in Q1 2025.
  • Median Interest Coverage Ratio over the past 5 years was 54.93 (2023), compared with a mean of 186.98.
  • Biggest five-year swings in Interest Coverage Ratio: skyrocketed 64.8% in 2021 and later plummeted 4200.62% in 2023.
  • TherapeuticsMD's Interest Coverage Ratio stood at 6.56 in 2021, then surged by 81.1% to 1.24 in 2022, then crashed by 7047.55% to 88.65 in 2023, then tumbled by 326.4% to 378.0 in 2024, then rose by 23.99% to 287.33 in 2025.
  • The last three reported values for Interest Coverage Ratio were 287.33 (Q3 2025), 347.5 (Q2 2025), and 640.5 (Q1 2025) per Business Quant data.